Who is sponsoring NCT04403217?

NCT04403217 is sponsored by Universidade Nova de Lisboa.

What drugs are being tested in NCT04403217?

Interventions in NCT04403217: Individualized structured dietary plan based on MD.

What condition does NCT04403217 study?

NCT04403217 studies Type 2 Diabetes.

Is NCT04403217 still recruiting?

NCT04403217 is currently status unknown. Last updated 27 May 2020.

Last reviewed 2020-05-27 · How we verify

NCT04403217: MEDBIOME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of MEDiterranean Diet on the microBIOME of Individuals With Type 2 Diabetes

Status unknown NA Last updated 27 May 2020

What this trial tests

NA trial testing Individualized structured dietary plan based on MD in Type 2 Diabetes in 30 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
31 July 2021

30 September 2021

Quick facts

Lead sponsor	Universidade Nova de Lisboa
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 April 2019
Primary completion	31 July 2021
Estimated completion	30 September 2021
Sites	1 location across Portugal

Drugs / interventions tested

Individualized structured dietary plan based on MD

Conditions studied

Type 2 Diabetes — all drugs for Type 2 Diabetes →

Sponsor

Universidade Nova de Lisboa — full company profile →

Who can join

Adults 40 to 80, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dysbiosis of gut microbiota is associated with the pathophysiology of type 2 diabetes. Mediterranean diet has been indicated as a dietary pattern that promote the integrity of gut barrier and that has positive impact in the metabolic control of subjects with type 2 diabetes. This is a 12-week, single-arm clinical study that aims to evaluate if the effect of Mediterranean diet in metabolic control of these subjects is mediated by gut microbiota. Subjects will receive personalized nutrition counseling where Mediterranean diet will be promoted.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN, Kim M, Bennett BJ. · · 2021 · cited 89× · PMID 33897618 · DOI 10.3389/fendo.2021.632335
A Pilot Study on the Metabolic Impact of Mediterranean Diet in Type 2 Diabetes: Is Gut Microbiota the Key?
Ismael S, Silvestre MP, Vasques M, Araújo JR, et al · · 2021 · cited 44× · PMID 33917736 · DOI 10.3390/nu13041228

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07254689 — The Food for Health Study · NA · recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Other Universidade Nova de Lisboa trials

Trials by the same sponsor.

NCT05593835 — Multimorbidity Management Supported by a Digital Platform · NA · not yet recruiting
NCT06794515 — cGMP: Metabolism and Appetite Modulation · NA · not yet recruiting
NCT05788952 — The Role of Intestinal and Vaginal Microbiota, Estrogenic Activity, Metabolic Profile & Nutritional Status in Endometrio · unknown
NCT05375487 — The Effect of Natural Carbonated Mineral Water Consumption on Gastrointestinal Transit and Gut Microbiota - A Randomized · NA · completed
NCT05840627 — Acute Satiety and Metabolic Response of Daily Consumption of a Fruit Juice · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04403217 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Nova de Lisboa
Last refreshed: 27 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04403217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing